205 related articles for article (PubMed ID: 19082568)
1. [Sugammadex. New pharmacological concept for antagonizing rocuronium and vecuronium].
Sparr HJ; Booij LH; Fuchs-Buder T
Anaesthesist; 2009 Jan; 58(1):66-80. PubMed ID: 19082568
[TBL] [Abstract][Full Text] [Related]
2. A randomized, dose-response study of sugammadex given for the reversal of deep rocuronium- or vecuronium-induced neuromuscular blockade under sevoflurane anesthesia.
Duvaldestin P; Kuizenga K; Saldien V; Claudius C; Servin F; Klein J; Debaene B; Heeringa M
Anesth Analg; 2010 Jan; 110(1):74-82. PubMed ID: 19933538
[TBL] [Abstract][Full Text] [Related]
3. Effective reversal of moderate rocuronium- or vecuronium-induced neuromuscular block with sugammadex, a selective relaxant binding agent.
Suy K; Morias K; Cammu G; Hans P; van Duijnhoven WG; Heeringa M; Demeyer I
Anesthesiology; 2007 Feb; 106(2):283-8. PubMed ID: 17264722
[TBL] [Abstract][Full Text] [Related]
4. Safety and tolerability of single intravenous doses of sugammadex administered simultaneously with rocuronium or vecuronium in healthy volunteers.
Cammu G; De Kam PJ; Demeyer I; Decoopman M; Peeters PA; Smeets JM; Foubert L
Br J Anaesth; 2008 Mar; 100(3):373-9. PubMed ID: 18238834
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy and safety of sugammadex (Org 25969) in reversing moderate neuromuscular block induced by rocuronium or vecuronium in Japanese patients].
Takeda J; Iwasaki H; Yamakage M; Ozaki M; Kawamata M; Hatano Y; Yorozuya T; Miyakawa H; Kanmura Y
Masui; 2014 Oct; 63(10):1075-82. PubMed ID: 25693332
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy and safety of sugammadex (Org 25969) in reversing deep neuromuscular block induced by rocuronium or vecuronium in Japanese patients].
Takeda J; Iwasaki H; Otagiri T; Katoh T; Shingu K; Obara H; Nakatsuka H; Tomiyama Y; Kasaba T
Masui; 2014 Oct; 63(10):1083-8. PubMed ID: 25693333
[TBL] [Abstract][Full Text] [Related]
7. [Sugammadex, a novel drug for neuromuscular blockade reversal].
Fernández Meré LA; Alvarez-Blanco M
Rev Esp Anestesiol Reanim; 2010 Feb; 57(2):95-102. PubMed ID: 20337001
[TBL] [Abstract][Full Text] [Related]
8. Sugammadex: a selective relaxant-binding agent providing rapid reversal.
Rex C; Bergner UA; Pühringer FK
Curr Opin Anaesthesiol; 2010 Aug; 23(4):461-5. PubMed ID: 20489603
[TBL] [Abstract][Full Text] [Related]
9. Neuromuscular transmission: new concepts and agents.
de Boer HD
J Crit Care; 2009 Mar; 24(1):36-42. PubMed ID: 19272537
[TBL] [Abstract][Full Text] [Related]
10. Sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade.
Abrishami A; Ho J; Wong J; Yin L; Chung F
Cochrane Database Syst Rev; 2009 Oct; (4):CD007362. PubMed ID: 19821409
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the potential for displacement interactions with sugammadex: a pharmacokinetic-pharmacodynamic modelling approach.
Zwiers A; van den Heuvel M; Smeets J; Rutherford S
Clin Drug Investig; 2011; 31(2):101-11. PubMed ID: 21067251
[TBL] [Abstract][Full Text] [Related]
12. The concept behind sugammadex.
Epemolu O; Bom A
Rev Esp Anestesiol Reanim; 2014 May; 61(5):272-6. PubMed ID: 24636599
[TBL] [Abstract][Full Text] [Related]
13. Clinical pharmacology and efficacy of sugammadex in the reversal of neuromuscular blockade.
Schaller SJ; Lewald H
Expert Opin Drug Metab Toxicol; 2016 Sep; 12(9):1097-108. PubMed ID: 27463265
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of cyclodextrin (sugammadex) for reversal of intense neuromuscular block of rocuronium and vecuronium, experimental and clinical studies.
Alkenany HM
J Egypt Soc Parasitol; 2013 Dec; 43(3):705-14. PubMed ID: 24640870
[TBL] [Abstract][Full Text] [Related]
15. Sugammadex rapidly reverses moderate rocuronium- or vecuronium-induced neuromuscular block during sevoflurane anaesthesia: a dose-response relationship.
Pühringer FK; Gordon M; Demeyer I; Sparr HJ; Ingimarsson J; Klarin B; van Duijnhoven W; Heeringa M
Br J Anaesth; 2010 Nov; 105(5):610-9. PubMed ID: 20876699
[TBL] [Abstract][Full Text] [Related]
16. An update on sugammadex sodium.
Welliver M; Cheek D
AANA J; 2009 Jun; 77(3):219-28. PubMed ID: 19645172
[TBL] [Abstract][Full Text] [Related]
17. Sugammadex: a cyclodextrin to reverse neuromuscular blockade in anaesthesia.
Donati F
Expert Opin Pharmacother; 2008 Jun; 9(8):1375-86. PubMed ID: 18473711
[TBL] [Abstract][Full Text] [Related]
18. Reversal of profound rocuronium or vecuronium-induced neuromuscular block with sugammadex in isoflurane-anaesthetised dogs.
Mosing M; Auer U; West E; Jones RS; Hunter JM
Vet J; 2012 Jun; 192(3):467-71. PubMed ID: 22030475
[TBL] [Abstract][Full Text] [Related]
19. Sugammadex: a review of its use in anaesthetic practice.
Yang LP; Keam SJ
Drugs; 2009; 69(7):919-42. PubMed ID: 19441874
[TBL] [Abstract][Full Text] [Related]
20. The Use of Sugammadex in a Patient With Guillain-Barre Syndrome: A Case Report.
Tezcan B; Bölükbaşi D; Kazanci D; Turan S; Suer Kaya G; Özgök A
A A Case Rep; 2017 Apr; 8(8):200-202. PubMed ID: 28151766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]